Cargando…
A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity
Despite the great potential of numerous antioxidants for pharmacotherapy of diseases associated with inflammation and oxidative stress, many challenges remain for their clinical translation. Herein, a superoxidase dismutase/catalase‐mimetic material based on Tempol and phenylboronic acid pinacol est...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193162/ https://www.ncbi.nlm.nih.gov/pubmed/30356945 http://dx.doi.org/10.1002/advs.201800781 |
_version_ | 1783364027126120448 |
---|---|
author | Li, Lanlan Guo, Jiawei Wang, Yuquan Xiong, Xiaoxing Tao, Hui Li, Jin Jia, Yi Hu, Houyuan Zhang, Jianxiang |
author_facet | Li, Lanlan Guo, Jiawei Wang, Yuquan Xiong, Xiaoxing Tao, Hui Li, Jin Jia, Yi Hu, Houyuan Zhang, Jianxiang |
author_sort | Li, Lanlan |
collection | PubMed |
description | Despite the great potential of numerous antioxidants for pharmacotherapy of diseases associated with inflammation and oxidative stress, many challenges remain for their clinical translation. Herein, a superoxidase dismutase/catalase‐mimetic material based on Tempol and phenylboronic acid pinacol ester simultaneously conjugated β‐cyclodextrin (abbreviated as TPCD), which is capable of eliminating a broad spectrum of reactive oxygen species (ROS), is reported. TPCD can be easily synthesized by sequentially conjugating two functional moieties onto a β‐cyclodextrin scaffold. The thus developed pharmacologically active material may be easily produced into antioxidant and anti‐inflammatory nanoparticles, with tunable size. TPCD nanoparticles (TPCD NP) effectively protect macrophages from oxidative stress‐induced apoptosis in vitro. Consistently, TPCD NP shows superior efficacies in three murine models of inflammatory diseases, with respect to attenuating inflammatory responses and mitigating oxidative stress. TPCD NP can also protect mice from drug‐induced organ toxicity. Besides the passive targeting effect, the broad spectrum ROS‐scavenging capability contributes to the therapeutic benefits of TPCD NP. Importantly, in vitro and in vivo preliminary experiments demonstrate the good safety profile of TPCD NP. Consequently, TPCD in its native and nanoparticle forms can be further developed as efficacious and safe therapies for treatment of inflammation and oxidative stress‐associated diseases. |
format | Online Article Text |
id | pubmed-6193162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61931622018-10-23 A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity Li, Lanlan Guo, Jiawei Wang, Yuquan Xiong, Xiaoxing Tao, Hui Li, Jin Jia, Yi Hu, Houyuan Zhang, Jianxiang Adv Sci (Weinh) Full Papers Despite the great potential of numerous antioxidants for pharmacotherapy of diseases associated with inflammation and oxidative stress, many challenges remain for their clinical translation. Herein, a superoxidase dismutase/catalase‐mimetic material based on Tempol and phenylboronic acid pinacol ester simultaneously conjugated β‐cyclodextrin (abbreviated as TPCD), which is capable of eliminating a broad spectrum of reactive oxygen species (ROS), is reported. TPCD can be easily synthesized by sequentially conjugating two functional moieties onto a β‐cyclodextrin scaffold. The thus developed pharmacologically active material may be easily produced into antioxidant and anti‐inflammatory nanoparticles, with tunable size. TPCD nanoparticles (TPCD NP) effectively protect macrophages from oxidative stress‐induced apoptosis in vitro. Consistently, TPCD NP shows superior efficacies in three murine models of inflammatory diseases, with respect to attenuating inflammatory responses and mitigating oxidative stress. TPCD NP can also protect mice from drug‐induced organ toxicity. Besides the passive targeting effect, the broad spectrum ROS‐scavenging capability contributes to the therapeutic benefits of TPCD NP. Importantly, in vitro and in vivo preliminary experiments demonstrate the good safety profile of TPCD NP. Consequently, TPCD in its native and nanoparticle forms can be further developed as efficacious and safe therapies for treatment of inflammation and oxidative stress‐associated diseases. John Wiley and Sons Inc. 2018-08-16 /pmc/articles/PMC6193162/ /pubmed/30356945 http://dx.doi.org/10.1002/advs.201800781 Text en © 2018 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Full Papers Li, Lanlan Guo, Jiawei Wang, Yuquan Xiong, Xiaoxing Tao, Hui Li, Jin Jia, Yi Hu, Houyuan Zhang, Jianxiang A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity |
title | A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity |
title_full | A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity |
title_fullStr | A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity |
title_full_unstemmed | A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity |
title_short | A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity |
title_sort | broad‐spectrum ros‐eliminating material for prevention of inflammation and drug‐induced organ toxicity |
topic | Full Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193162/ https://www.ncbi.nlm.nih.gov/pubmed/30356945 http://dx.doi.org/10.1002/advs.201800781 |
work_keys_str_mv | AT lilanlan abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT guojiawei abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT wangyuquan abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT xiongxiaoxing abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT taohui abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT lijin abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT jiayi abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT huhouyuan abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT zhangjianxiang abroadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT lilanlan broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT guojiawei broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT wangyuquan broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT xiongxiaoxing broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT taohui broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT lijin broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT jiayi broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT huhouyuan broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity AT zhangjianxiang broadspectrumroseliminatingmaterialforpreventionofinflammationanddruginducedorgantoxicity |